Cargando…
Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer
Interleukin-6 (IL-6) is known to be involved in the pathogenesis of cancer progression. IL-6-174G>C polymorphism has shown several results in association studies. In this study, we evaluated the association the IL-6-174G>C polymorphism and overall survival (OS) of cancer using 17 eligible stud...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546496/ https://www.ncbi.nlm.nih.gov/pubmed/28548958 http://dx.doi.org/10.18632/oncotarget.17771 |
_version_ | 1783255560584429568 |
---|---|
author | Zhai, Kan Yang, Yong Gao, Zhi-Gang Ding, Jie |
author_facet | Zhai, Kan Yang, Yong Gao, Zhi-Gang Ding, Jie |
author_sort | Zhai, Kan |
collection | PubMed |
description | Interleukin-6 (IL-6) is known to be involved in the pathogenesis of cancer progression. IL-6-174G>C polymorphism has shown several results in association studies. In this study, we evaluated the association the IL-6-174G>C polymorphism and overall survival (OS) of cancer using 17 eligible studies with 4,304 patients. Our meta-analysis indicated that IL-6-174G>C polymorphism is not associated with OS when assessed using 3 genotype comparison including GG/(GC+CC), CC/(GC+GG) and CC/GG. Interestingly, compared to GG carrier, patients with IL-6-174GC genotype showed a decreased hazard of poor OS (hazard ratio = 0.81, 95% confidence interval: 0.68–0.96, P = 0.018; I(2) = 34.5%, Phet = 0.107). However, for GG/(GC+CC) genotype comparison, this SNP is affect patients’ OS obviously in bladder cancer, ovarian and peritoneal cancer, neuroblastoma, gastric cancer and osteosarcoma, though pooled results showing negative association because adverse and protective effect on different type of cancer balance each other. These results suggest IL-6-174G>C polymorphism might play a role in modulating OS in different type of cancer and might contribute to individual treatment in the future. |
format | Online Article Text |
id | pubmed-5546496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-55464962017-08-23 Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer Zhai, Kan Yang, Yong Gao, Zhi-Gang Ding, Jie Oncotarget Research Paper Interleukin-6 (IL-6) is known to be involved in the pathogenesis of cancer progression. IL-6-174G>C polymorphism has shown several results in association studies. In this study, we evaluated the association the IL-6-174G>C polymorphism and overall survival (OS) of cancer using 17 eligible studies with 4,304 patients. Our meta-analysis indicated that IL-6-174G>C polymorphism is not associated with OS when assessed using 3 genotype comparison including GG/(GC+CC), CC/(GC+GG) and CC/GG. Interestingly, compared to GG carrier, patients with IL-6-174GC genotype showed a decreased hazard of poor OS (hazard ratio = 0.81, 95% confidence interval: 0.68–0.96, P = 0.018; I(2) = 34.5%, Phet = 0.107). However, for GG/(GC+CC) genotype comparison, this SNP is affect patients’ OS obviously in bladder cancer, ovarian and peritoneal cancer, neuroblastoma, gastric cancer and osteosarcoma, though pooled results showing negative association because adverse and protective effect on different type of cancer balance each other. These results suggest IL-6-174G>C polymorphism might play a role in modulating OS in different type of cancer and might contribute to individual treatment in the future. Impact Journals LLC 2017-05-10 /pmc/articles/PMC5546496/ /pubmed/28548958 http://dx.doi.org/10.18632/oncotarget.17771 Text en Copyright: © 2017 Zhai et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Zhai, Kan Yang, Yong Gao, Zhi-Gang Ding, Jie Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer |
title | Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer |
title_full | Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer |
title_fullStr | Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer |
title_full_unstemmed | Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer |
title_short | Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer |
title_sort | interleukin-6-174g>c gene promoter polymorphism and prognosis in patients with cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546496/ https://www.ncbi.nlm.nih.gov/pubmed/28548958 http://dx.doi.org/10.18632/oncotarget.17771 |
work_keys_str_mv | AT zhaikan interleukin6174gcgenepromoterpolymorphismandprognosisinpatientswithcancer AT yangyong interleukin6174gcgenepromoterpolymorphismandprognosisinpatientswithcancer AT gaozhigang interleukin6174gcgenepromoterpolymorphismandprognosisinpatientswithcancer AT dingjie interleukin6174gcgenepromoterpolymorphismandprognosisinpatientswithcancer |